Another View Academics for Informed Consent
“The OHRP and SUPPORT — Another View” by a group of 45 physicians, ethicists, and scholars in allied fields who have stepped up to the plate to express their support for OHRP’s determination. . . .
“The OHRP and SUPPORT — Another View” by a group of 45 physicians, ethicists, and scholars in allied fields who have stepped up to the plate to express their support for OHRP’s determination. . . .
“In real ethics, there are some things that must never be done. Bioethics is . . . enticed onward by the question, Why not?. . .
Newly obtained documents from the SUPPORT oxygen experiment on tiny premature babies reveal far more extensive medical ethics violations. . . .
Disclosure of the egregious ethical, methodological and legal violations outlined in the letter of determination by the Federal Office of Human Research Protections (OHRP) regarding the so-called SUPPORT oxygen experiment. . . .
“Unfortunately, the entire evidence base has been perverted,” said Joseph Ross, a professor at Yale Medical School who has studied the issue.
Part III. The Untouchable Third Rail in Healthcare—The Vaccine Controversy: Core Issues
An urgent call for a debate about the ethics of data secrecy. Absent the humanitarian raison d’etre for enrolling in a clinical trial, no human being should be put at any–even minimal risk–without adequate compensation as a laborer and the protection of Workmen’s Compensation insurance.
"Shocking as it may seem, U.S. government doctors once thought it was fine to experiment on disabled people and prison inmates." Associated Press, Feb 27, 2011
"Among all the problematic suggestions for DSM5, the proposal for a "Psychosis Risk Syndrome" stands out as the most ill–conceived and potentially harmful." Allen Frances, MD
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
This young child represents millions of children in the United States who are falling prey to licensed, but irresponsible prescribers of toxic drugs.